Home | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
AACL AACL AACL AACL
BSAAM Logo
AACL Logo
BSAAM's Anti Ageing Conference London 2018
Follow us on ...
Facebook  Twitter  Instagram
Conference Information
2017 Speaker List and Presentations
Download 2017 Feedback Form (Required for Credits)
Download 2017 Workshop Feedback Form (Required for Credits)
Download 2017 Program
2017 Program
2017 Exhibitors
2017 Pre-Conference Workshops
2017 Exhibitors Form
2017 Peer Review Board Members
   
Delegate Information
2017 VENUE: The Kensington Town Hall - MAP
Nearby London Accommodations
   
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
   
Past Conference Information
  2016
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAM's AACL 2016 Peer Review Board Members
  2015
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAM's AACL 2015 Peer Review Board Members
  2014
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
  2013
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
  2012
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
  2011
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
  2010
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
  2009
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
  2008
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  2006
  3rd Annual Anti-Ageing Conference Manual (2006)
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  2005
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  2004
  Past Speakers 2004
  2002
  Past Speakers Monte Carlo 2002
   
BSAAM's AACL Organizer
BSAAM
BSAAM Affiliates
waaam
   
   
A4M
   
wosaam
AACL Supporters
HB Health
www.hbhealth.com
   
CPD
   
  BANT
   
 
   
 
   
  Sun Chlorella
   
 
   
enerzona
   
BHMA
   
WOCPM
   
FACE
   
IAAS
   
Dole
   
 
   
 
   
   

AACL 2008 Speaker

HaqProfessor Syed E A Haq MB BS BSc (HON) PhD DIC MRCP(UK)
Professor Syed Haq, is a Consultant Physician and Founder of The London Preventative Medicine Centre. He is the Clinical and Scientific Director of Daval International Ltd., a biopharmaceutical company developing a platform for the treatment of autoimmune (e.g., Systemic Sclerosis), neurodegenerative (e.g., Motor neuron disease, Alzheimer’s disease, Myasthenia Gravis, Multiple Sclerosis) and inflammatory (e.g., Rheumatoid arthritis) diseases using a patented polyclonal antibody/peptide composite which has recently completed two phase II clinical trials in the UK. He has worked and trained at some of the foremost institutions - Guy’s Hospital, Hammersmith and Royal Brompton Hospitals, Imperial College, Massachusetts General Hospital, Harvard Medical School, and Tufts University, New England Medical Center Hospitals Inc.

Prof. Haq has published peer-reviewed articles in several internationally renowned scientific journals including PNAS and Nature Medicine. He has been co-chairman of the Anti-ageing Conference London (2008-11), and has been an invited presenter/speaker at numerous international conferences (American Heart Association, American College of Cardiology, Anti-Ageing Medicine World Congress and the NCD National Workshop, India). Prof. Haq has received several national and international awards/fellowships from the Medical Research Council, Wellcome Trust International, American Heart Association, Astra Zeneca and the Heart Failure Society of America.

2008 - Cytosolic Phospholipase A2 is fundamental in regulating insulin-like growth factor-1 mediated signalling and mammalian growth.

Phospholipase A2s comprise a family of enzymes that act at the sn-2 position of phospholipids (PLs), generating a free fatty acid and lysophospholipid. As the sn-2 position of PLs is enriched with arachidonic acid (AA), an eicosanoid precursor, PLA2 activity has important implications for the control of eicosanoid production. The 85 kDa cytosolic PLA2 (c-PLA2) plays a central role in AA release and eicosanoid generation. Based on in vivo studies, generation of AA by the ubiquitously expressed cytosolic phospholipase A2 (PLA2) plays a fundamental role in the regulation of cellular homeostasis, normal parturition, inflammation, and tumourigenesis. In our studies we report that cytosolic PLA2 is a negative regulator of growth, specifically of striated muscle. We find that normal growth of skeletal muscle, and normal and pathologic stress-induced hypertrophic growth of the heart are exaggerated in a mouse deleted for the gene encoding cytosolic PLA2. Evidence suggests that the physiologically relevant activator of the pathway that regulates normal post-natal growth is insulin-like growth factor-1 (IGF-1), acting via its receptor and the insulin receptor substrate-1 (IRS-1). IGF-1 signalling has also been implicated in pathologic stress-induced hypertrophic growth of the heart. The mechanism underlying the exaggerated growth phenotype is that cytosolic PLA2 negatively regulates IGF-1 signalling. Absence of cytosolic PLA2 leads to sustained activation of the IGF-1 pathway, which results from 3’-phosphoinositide-dependent kinase-1 (PDK1’s) failure to recruit and phosphorylate protein kinase C z, a negative regulator of IGF-1 signalling. Importantly, AA restores activation of PKC z, correcting the exaggerated IGF-1 signalling. In conclusion, these results have important implications for normal mammalian growth and ageing. They indicate that cytosolic PLA2 and AA critically regulate striated muscle growth by modulating multiple growth regulatory pathways. The findings identify a novel role for cytosolic PLA2 as a negative regulator both of IGF-1 signalling, and of normal and pathologic growth of striated muscle

Home | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :
london@antiageingconference.com
mariasomers@bsaam.com